FDA label 6a6181f1-82fc-47c4-b17e-6825f693f7a8

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID: e564a9dc-e856-479c-b232-45db9d259201
SPL ID: 6a6181f1-82fc-47c4-b17e-6825f693f7a8
Version: 1
Effective date: 2013-08-16
Source export date: 2026-11-06
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/b00a73f24c6ff050408c570063640e3d80d1f71dfc9a165d1cf072a25659445a/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 06:58:38

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 2 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
spl id		6a6181f1-82fc-47c4-b17e-6825f693f7a8	id
spl set id		e564a9dc-e856-479c-b232-45db9d259201	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

- Stop using the treatment if sensitivities as below occurs and consult with dermatologist - sensitivities such as red marks, intumescence, urtication, irritation during use -Have sensitivities as above on applied part by direct sun ray - Do not use the shampoo on the part of scar, eczema, dermatitis and etc. - Wash away immediately if shampoo get in our eyes. - throughly rinse after use. Improper washing may cause hair loss, decolor of your hair. - Storage and handling - Close lid after use. - Do not store at high and low temperatures and avoid sunlight.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.